Anbio Biotechnology Retained Earnings
Anbio Biotechnology (NNNN) had Retained Earnings of $23.58 million as of 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Balance Sheet › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-04-07
- 2025-12-31: Retained Earnings (Accumulated Deficit) $23.58M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) $17.17M.
- 2023-12-31: Retained Earnings (Accumulated Deficit) $14.80M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-12-31 | $23.58M 20-F · filed 2026-04-07 |
| 2024-12-31 | $17.17M 20-F · filed 2026-04-07 |
| 2023-12-31 | $14.80M 20-F · filed 2025-04-28 |